Loading…

Orbital Cavernous Haemangiomas: Immunohistochemical Study of Proliferative Capacity, Vascular Differentiation and Hormonal Receptor Status

Background/Aims: Immunohistochemical characterisation of orbital cavernous haemangiomas (CHs) with respect to proliferative capacity, hormone receptor status and vascular differentiation. Methods: Eleven cases of orbital CHs were reviewed. Immunohistochemical stains for Mib-1, proliferating cell nuc...

Full description

Saved in:
Bibliographic Details
Published in:Orbit (Amsterdam) 2012-12, Vol.31 (6), p.386-389
Main Authors: Gupta, Aanchal, Prabhakaran, Venkatesh C., Dodd, Tom, Davis, Garry, Selva, Dinesh
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c484t-81da2162ea3dd13aa87c027e3beec3d8c061ba1dbb3e0979a592d41f0d4b51933
cites cdi_FETCH-LOGICAL-c484t-81da2162ea3dd13aa87c027e3beec3d8c061ba1dbb3e0979a592d41f0d4b51933
container_end_page 389
container_issue 6
container_start_page 386
container_title Orbit (Amsterdam)
container_volume 31
creator Gupta, Aanchal
Prabhakaran, Venkatesh C.
Dodd, Tom
Davis, Garry
Selva, Dinesh
description Background/Aims: Immunohistochemical characterisation of orbital cavernous haemangiomas (CHs) with respect to proliferative capacity, hormone receptor status and vascular differentiation. Methods: Eleven cases of orbital CHs were reviewed. Immunohistochemical stains for Mib-1, proliferating cell nuclear antigen (PCNA), Bcl-2, estrogen and progesterone receptors (ER & PR), CD31, D2-40, and VEGF were investigated in 11 specimens. Results: Immunohistochemical staining revealed positivity for PCNA in ten of the 11 cases (91%). Bcl-2 was positive in 8 cases (73%). VEGF and PR were each weakly positive in 3 cases. All cases were negative for Mib-1, ER and D2-40. The staining was localized around the endothelium. Conclusion: This is the first study to characterise in detail the immunohistochemical features of orbital CHs. The proliferative markers PCNA and Mib-1 show discordant expression in these lesions and the expression of PCNA and Bcl-2 in the absence of Mib-1 is indicative of low proliferative potential. Small subsets of these tumors express PR and VEGF, which may partly explain the proliferative capacity of some orbital CHs.
doi_str_mv 10.3109/01676830.2012.711887
format article
fullrecord <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_informahealthcare_journals_10_3109_01676830_2012_711887</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1238104106</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-81da2162ea3dd13aa87c027e3beec3d8c061ba1dbb3e0979a592d41f0d4b51933</originalsourceid><addsrcrecordid>eNp9kc1u1DAURi0EotPCGyCUJQsy-MaZxMMChKbAVKpUxN_WurFvGFeJPbWdonkFnhpH0yKx6coLn3uu_X2MvQC-FMDXbzg0bSMFX1YcqmULIGX7iC2gretyBVw-ZosZKWfmhJ3GeM05F7LmT9lJJbiUQlYL9ucqdDbhUGzwloLzUyy2SCO6X9aPGN8WF-M4Ob-zMXm9o9HqzH5LkzkUvi--BD_YngIme0tZsUdt0-F18ROjngYMxbnt8zW5ZDPiXYHOFFsfRu-y5itp2icfsg_TFJ-xJz0OkZ7fnWfsx6eP3zfb8vLq88Xmw2Wpa1mnUoLBCpqKUBgDAlG2mlctiY5ICyM1b6BDMF0niK_bNa7Wlamh56buVrAW4oy9Onr3wd9MFJMabdQ0DOgo_19BJSTwGniT0fqI6uBjDNSrfbAjhoMCruYW1H0Lam5BHVvIYy_vNkzdSObf0H3sGXh_BKzrcxr424fBqISHwYc-oNM2zvoHV7z7z7AjHNJOYyB17aeQ440Pv_Evuo2tJQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1238104106</pqid></control><display><type>article</type><title>Orbital Cavernous Haemangiomas: Immunohistochemical Study of Proliferative Capacity, Vascular Differentiation and Hormonal Receptor Status</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Gupta, Aanchal ; Prabhakaran, Venkatesh C. ; Dodd, Tom ; Davis, Garry ; Selva, Dinesh</creator><creatorcontrib>Gupta, Aanchal ; Prabhakaran, Venkatesh C. ; Dodd, Tom ; Davis, Garry ; Selva, Dinesh</creatorcontrib><description>Background/Aims: Immunohistochemical characterisation of orbital cavernous haemangiomas (CHs) with respect to proliferative capacity, hormone receptor status and vascular differentiation. Methods: Eleven cases of orbital CHs were reviewed. Immunohistochemical stains for Mib-1, proliferating cell nuclear antigen (PCNA), Bcl-2, estrogen and progesterone receptors (ER &amp; PR), CD31, D2-40, and VEGF were investigated in 11 specimens. Results: Immunohistochemical staining revealed positivity for PCNA in ten of the 11 cases (91%). Bcl-2 was positive in 8 cases (73%). VEGF and PR were each weakly positive in 3 cases. All cases were negative for Mib-1, ER and D2-40. The staining was localized around the endothelium. Conclusion: This is the first study to characterise in detail the immunohistochemical features of orbital CHs. The proliferative markers PCNA and Mib-1 show discordant expression in these lesions and the expression of PCNA and Bcl-2 in the absence of Mib-1 is indicative of low proliferative potential. Small subsets of these tumors express PR and VEGF, which may partly explain the proliferative capacity of some orbital CHs.</description><identifier>ISSN: 0167-6830</identifier><identifier>EISSN: 1744-5108</identifier><identifier>DOI: 10.3109/01676830.2012.711887</identifier><identifier>PMID: 23088382</identifier><language>eng</language><publisher>England: Informa Healthcare</publisher><subject>Antibodies, Monoclonal, Murine-Derived - metabolism ; Biomarkers, Tumor - metabolism ; Cavernous haemangioma ; Cell Differentiation ; Cell Proliferation ; Differentiation ; Hemangioma, Cavernous - metabolism ; Humans ; Immunohistochemistry ; Orbital Neoplasms - metabolism ; Platelet Endothelial Cell Adhesion Molecule-1 - metabolism ; Proliferating Cell Nuclear Antigen - metabolism ; Proliferation ; Receptors, Estrogen - metabolism ; Receptors, Progesterone - metabolism ; Vascular Endothelial Growth Factor A - metabolism</subject><ispartof>Orbit (Amsterdam), 2012-12, Vol.31 (6), p.386-389</ispartof><rights>2012 Informa Healthcare USA, Inc. 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-81da2162ea3dd13aa87c027e3beec3d8c061ba1dbb3e0979a592d41f0d4b51933</citedby><cites>FETCH-LOGICAL-c484t-81da2162ea3dd13aa87c027e3beec3d8c061ba1dbb3e0979a592d41f0d4b51933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23088382$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gupta, Aanchal</creatorcontrib><creatorcontrib>Prabhakaran, Venkatesh C.</creatorcontrib><creatorcontrib>Dodd, Tom</creatorcontrib><creatorcontrib>Davis, Garry</creatorcontrib><creatorcontrib>Selva, Dinesh</creatorcontrib><title>Orbital Cavernous Haemangiomas: Immunohistochemical Study of Proliferative Capacity, Vascular Differentiation and Hormonal Receptor Status</title><title>Orbit (Amsterdam)</title><addtitle>Orbit</addtitle><description>Background/Aims: Immunohistochemical characterisation of orbital cavernous haemangiomas (CHs) with respect to proliferative capacity, hormone receptor status and vascular differentiation. Methods: Eleven cases of orbital CHs were reviewed. Immunohistochemical stains for Mib-1, proliferating cell nuclear antigen (PCNA), Bcl-2, estrogen and progesterone receptors (ER &amp; PR), CD31, D2-40, and VEGF were investigated in 11 specimens. Results: Immunohistochemical staining revealed positivity for PCNA in ten of the 11 cases (91%). Bcl-2 was positive in 8 cases (73%). VEGF and PR were each weakly positive in 3 cases. All cases were negative for Mib-1, ER and D2-40. The staining was localized around the endothelium. Conclusion: This is the first study to characterise in detail the immunohistochemical features of orbital CHs. The proliferative markers PCNA and Mib-1 show discordant expression in these lesions and the expression of PCNA and Bcl-2 in the absence of Mib-1 is indicative of low proliferative potential. Small subsets of these tumors express PR and VEGF, which may partly explain the proliferative capacity of some orbital CHs.</description><subject>Antibodies, Monoclonal, Murine-Derived - metabolism</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Cavernous haemangioma</subject><subject>Cell Differentiation</subject><subject>Cell Proliferation</subject><subject>Differentiation</subject><subject>Hemangioma, Cavernous - metabolism</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Orbital Neoplasms - metabolism</subject><subject>Platelet Endothelial Cell Adhesion Molecule-1 - metabolism</subject><subject>Proliferating Cell Nuclear Antigen - metabolism</subject><subject>Proliferation</subject><subject>Receptors, Estrogen - metabolism</subject><subject>Receptors, Progesterone - metabolism</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><issn>0167-6830</issn><issn>1744-5108</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAURi0EotPCGyCUJQsy-MaZxMMChKbAVKpUxN_WurFvGFeJPbWdonkFnhpH0yKx6coLn3uu_X2MvQC-FMDXbzg0bSMFX1YcqmULIGX7iC2gretyBVw-ZosZKWfmhJ3GeM05F7LmT9lJJbiUQlYL9ucqdDbhUGzwloLzUyy2SCO6X9aPGN8WF-M4Ob-zMXm9o9HqzH5LkzkUvi--BD_YngIme0tZsUdt0-F18ROjngYMxbnt8zW5ZDPiXYHOFFsfRu-y5itp2icfsg_TFJ-xJz0OkZ7fnWfsx6eP3zfb8vLq88Xmw2Wpa1mnUoLBCpqKUBgDAlG2mlctiY5ICyM1b6BDMF0niK_bNa7Wlamh56buVrAW4oy9Onr3wd9MFJMabdQ0DOgo_19BJSTwGniT0fqI6uBjDNSrfbAjhoMCruYW1H0Lam5BHVvIYy_vNkzdSObf0H3sGXh_BKzrcxr424fBqISHwYc-oNM2zvoHV7z7z7AjHNJOYyB17aeQ440Pv_Evuo2tJQ</recordid><startdate>201212</startdate><enddate>201212</enddate><creator>Gupta, Aanchal</creator><creator>Prabhakaran, Venkatesh C.</creator><creator>Dodd, Tom</creator><creator>Davis, Garry</creator><creator>Selva, Dinesh</creator><general>Informa Healthcare</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201212</creationdate><title>Orbital Cavernous Haemangiomas: Immunohistochemical Study of Proliferative Capacity, Vascular Differentiation and Hormonal Receptor Status</title><author>Gupta, Aanchal ; Prabhakaran, Venkatesh C. ; Dodd, Tom ; Davis, Garry ; Selva, Dinesh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-81da2162ea3dd13aa87c027e3beec3d8c061ba1dbb3e0979a592d41f0d4b51933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antibodies, Monoclonal, Murine-Derived - metabolism</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Cavernous haemangioma</topic><topic>Cell Differentiation</topic><topic>Cell Proliferation</topic><topic>Differentiation</topic><topic>Hemangioma, Cavernous - metabolism</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Orbital Neoplasms - metabolism</topic><topic>Platelet Endothelial Cell Adhesion Molecule-1 - metabolism</topic><topic>Proliferating Cell Nuclear Antigen - metabolism</topic><topic>Proliferation</topic><topic>Receptors, Estrogen - metabolism</topic><topic>Receptors, Progesterone - metabolism</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gupta, Aanchal</creatorcontrib><creatorcontrib>Prabhakaran, Venkatesh C.</creatorcontrib><creatorcontrib>Dodd, Tom</creatorcontrib><creatorcontrib>Davis, Garry</creatorcontrib><creatorcontrib>Selva, Dinesh</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Orbit (Amsterdam)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gupta, Aanchal</au><au>Prabhakaran, Venkatesh C.</au><au>Dodd, Tom</au><au>Davis, Garry</au><au>Selva, Dinesh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Orbital Cavernous Haemangiomas: Immunohistochemical Study of Proliferative Capacity, Vascular Differentiation and Hormonal Receptor Status</atitle><jtitle>Orbit (Amsterdam)</jtitle><addtitle>Orbit</addtitle><date>2012-12</date><risdate>2012</risdate><volume>31</volume><issue>6</issue><spage>386</spage><epage>389</epage><pages>386-389</pages><issn>0167-6830</issn><eissn>1744-5108</eissn><abstract>Background/Aims: Immunohistochemical characterisation of orbital cavernous haemangiomas (CHs) with respect to proliferative capacity, hormone receptor status and vascular differentiation. Methods: Eleven cases of orbital CHs were reviewed. Immunohistochemical stains for Mib-1, proliferating cell nuclear antigen (PCNA), Bcl-2, estrogen and progesterone receptors (ER &amp; PR), CD31, D2-40, and VEGF were investigated in 11 specimens. Results: Immunohistochemical staining revealed positivity for PCNA in ten of the 11 cases (91%). Bcl-2 was positive in 8 cases (73%). VEGF and PR were each weakly positive in 3 cases. All cases were negative for Mib-1, ER and D2-40. The staining was localized around the endothelium. Conclusion: This is the first study to characterise in detail the immunohistochemical features of orbital CHs. The proliferative markers PCNA and Mib-1 show discordant expression in these lesions and the expression of PCNA and Bcl-2 in the absence of Mib-1 is indicative of low proliferative potential. Small subsets of these tumors express PR and VEGF, which may partly explain the proliferative capacity of some orbital CHs.</abstract><cop>England</cop><pub>Informa Healthcare</pub><pmid>23088382</pmid><doi>10.3109/01676830.2012.711887</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0167-6830
ispartof Orbit (Amsterdam), 2012-12, Vol.31 (6), p.386-389
issn 0167-6830
1744-5108
language eng
recordid cdi_informahealthcare_journals_10_3109_01676830_2012_711887
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Antibodies, Monoclonal, Murine-Derived - metabolism
Biomarkers, Tumor - metabolism
Cavernous haemangioma
Cell Differentiation
Cell Proliferation
Differentiation
Hemangioma, Cavernous - metabolism
Humans
Immunohistochemistry
Orbital Neoplasms - metabolism
Platelet Endothelial Cell Adhesion Molecule-1 - metabolism
Proliferating Cell Nuclear Antigen - metabolism
Proliferation
Receptors, Estrogen - metabolism
Receptors, Progesterone - metabolism
Vascular Endothelial Growth Factor A - metabolism
title Orbital Cavernous Haemangiomas: Immunohistochemical Study of Proliferative Capacity, Vascular Differentiation and Hormonal Receptor Status
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T19%3A33%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Orbital%20Cavernous%20Haemangiomas:%20Immunohistochemical%20Study%20of%20Proliferative%20Capacity,%20Vascular%20Differentiation%20and%20Hormonal%20Receptor%20Status&rft.jtitle=Orbit%20(Amsterdam)&rft.au=Gupta,%20Aanchal&rft.date=2012-12&rft.volume=31&rft.issue=6&rft.spage=386&rft.epage=389&rft.pages=386-389&rft.issn=0167-6830&rft.eissn=1744-5108&rft_id=info:doi/10.3109/01676830.2012.711887&rft_dat=%3Cproquest_infor%3E1238104106%3C/proquest_infor%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c484t-81da2162ea3dd13aa87c027e3beec3d8c061ba1dbb3e0979a592d41f0d4b51933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1238104106&rft_id=info:pmid/23088382&rfr_iscdi=true